Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells

Radioiodine is a routine therapy for differentiated thyroid cancers. Non-thyroid cancers can intake radioiodine after transfection of the human sodium iodide symporter (hNIS) gene. The human telomerase reverse transcriptase (hTERT) promoter, an excellent tumor-specific promoter, has potential value...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Jian, Li, Wei, Wang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sun Yat-sen University Cancer Center 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013408/
https://www.ncbi.nlm.nih.gov/pubmed/21801606
http://dx.doi.org/10.5732/cjc.010.10580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013408/
https://www.ncbi.nlm.nih.gov/pubmed/21801606
http://dx.doi.org/10.5732/cjc.010.10580

Ejemplares similares